Market Cap 2.91B
Revenue (ttm) 0.00
Net Income (ttm) -109.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.05
Volume 322,500
Avg Vol 439,650
Day's Range N/A - N/A
Shares Out 34.77M
Stochastic %K 59%
Beta 0.80
Analysts Strong Sell
Price Target $108.82

Company Profile

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeost...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 674 9274
Address:
321 Arsenal Street, Suite 101, Watertown, United States
IN0V8
IN0V8 Oct. 24 at 7:24 PM
$IRON Buy Jefferies raises target price to $127 from $111
0 · Reply
Jamonda
Jamonda Oct. 22 at 5:26 PM
In case anyone missed it. $IRON offering priced at $84.00 1. Company sold 2,619,049 shares + 59,523 pre-funded warrants (ex. price $0.0001) 2. Selling shareholders sold 297,619 shares 3. Underwriters exercised full over-allotment (446,428 shares) on Oct 21, 2025 Net new (dilutive): ~2.679M shares (including warrants when exercised) Secondary: ~744k shares Total to public: ~3.363M shares + 59.5k warrants From: https://ir.discmedicine.com/static-files/57f167cc-4582-44c0-a1c6-520a7edcb2a9
1 · Reply
Strangperson
Strangperson Oct. 22 at 4:04 PM
$IRON my only green stock. Guess I should have bought bynd 😆
0 · Reply
S_Franconi
S_Franconi Oct. 21 at 3:51 PM
0 · Reply
S_Franconi
S_Franconi Oct. 20 at 1:26 PM
$IRON Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ir.discmedicine.com/news-releases/news-release-details/disc-medicine-announces-proposed-public-offering-common-stock-1
0 · Reply
S_Franconi
S_Franconi Oct. 20 at 1:26 PM
$IRON Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones https://ir.discmedicine.com/news-releases/news-release-details/disc-medicine-provides-update-hematology-portfolio-and-outlines
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 20 at 12:52 PM
$IRON (-2.7% pre) Disc Medicine announces $220M public stock offering https://ooc.bz/l/81184
0 · Reply
StockBraker
StockBraker Oct. 20 at 11:06 AM
$IRON Disc Medicine announces proposed public offering of common stock and pre-funded warrants
0 · Reply
fallondpicks
fallondpicks Oct. 19 at 9:42 PM
19 #stockbreakouts $IRON (gap), $LBRT (base and 200-day MA), $ACHV (gap). Two sub-$1, five $1-2.
2 · Reply
RunnerSignals
RunnerSignals Oct. 17 at 8:22 PM
Top Movers!​ $ACHV $IRON flying on FDA vouchers $BYND buying time with debt swap while $AGH quietly climbing day 5 https://stocksrunner.com/news/2025-10-17-top-movers-and-shakers-making-waves-in-today-trading-session
0 · Reply
Latest News on IRON
Disc Medicine Appoints Nadim Ahmed to its Board of Directors

Jul 14, 2025, 8:30 AM EDT - 3 months ago

Disc Medicine Appoints Nadim Ahmed to its Board of Directors


Disc Medicine to Participate in Upcoming Investor Conferences

May 28, 2025, 4:01 PM EDT - 5 months ago

Disc Medicine to Participate in Upcoming Investor Conferences


Disc Medicine: Forging Ahead In Hematology

Apr 9, 2025, 7:13 AM EDT - 7 months ago

Disc Medicine: Forging Ahead In Hematology


Disc Medicine Announces Underwritten Offering of Common Stock

Jun 14, 2024, 8:03 AM EDT - 1 year ago

Disc Medicine Announces Underwritten Offering of Common Stock


FDA Grants Orphan Drug Designation to 9MW3011

Feb 20, 2024, 9:00 AM EST - 1 year ago

FDA Grants Orphan Drug Designation to 9MW3011


IN0V8
IN0V8 Oct. 24 at 7:24 PM
$IRON Buy Jefferies raises target price to $127 from $111
0 · Reply
Jamonda
Jamonda Oct. 22 at 5:26 PM
In case anyone missed it. $IRON offering priced at $84.00 1. Company sold 2,619,049 shares + 59,523 pre-funded warrants (ex. price $0.0001) 2. Selling shareholders sold 297,619 shares 3. Underwriters exercised full over-allotment (446,428 shares) on Oct 21, 2025 Net new (dilutive): ~2.679M shares (including warrants when exercised) Secondary: ~744k shares Total to public: ~3.363M shares + 59.5k warrants From: https://ir.discmedicine.com/static-files/57f167cc-4582-44c0-a1c6-520a7edcb2a9
1 · Reply
Strangperson
Strangperson Oct. 22 at 4:04 PM
$IRON my only green stock. Guess I should have bought bynd 😆
0 · Reply
S_Franconi
S_Franconi Oct. 21 at 3:51 PM
0 · Reply
S_Franconi
S_Franconi Oct. 20 at 1:26 PM
$IRON Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ir.discmedicine.com/news-releases/news-release-details/disc-medicine-announces-proposed-public-offering-common-stock-1
0 · Reply
S_Franconi
S_Franconi Oct. 20 at 1:26 PM
$IRON Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones https://ir.discmedicine.com/news-releases/news-release-details/disc-medicine-provides-update-hematology-portfolio-and-outlines
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 20 at 12:52 PM
$IRON (-2.7% pre) Disc Medicine announces $220M public stock offering https://ooc.bz/l/81184
0 · Reply
StockBraker
StockBraker Oct. 20 at 11:06 AM
$IRON Disc Medicine announces proposed public offering of common stock and pre-funded warrants
0 · Reply
fallondpicks
fallondpicks Oct. 19 at 9:42 PM
19 #stockbreakouts $IRON (gap), $LBRT (base and 200-day MA), $ACHV (gap). Two sub-$1, five $1-2.
2 · Reply
RunnerSignals
RunnerSignals Oct. 17 at 8:22 PM
Top Movers!​ $ACHV $IRON flying on FDA vouchers $BYND buying time with debt swap while $AGH quietly climbing day 5 https://stocksrunner.com/news/2025-10-17-top-movers-and-shakers-making-waves-in-today-trading-session
0 · Reply
MaverikIT
MaverikIT Oct. 17 at 8:12 PM
@IsabellaDC @TheLongVol @Wigglyick been taking your $IRON sup?
1 · Reply
vector_bot09
vector_bot09 Oct. 17 at 6:10 PM
$IRON 📈 Platform strategy is a moat. If your assay runs on equipment that buyers already trust, the sales cycle shortens. Shorter cycles mean faster cash conversion and better R R. That combination is what long term holders hunt for in early diagnostics
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 4:20 PM
Raymond James has adjusted their stance on Disc Medicine ( $IRON ), setting the rating to Strong Buy with a target price of 89 → 108.
0 · Reply
topstockalerts
topstockalerts Oct. 17 at 3:27 PM
$IRON following closely 👀
0 · Reply
prismmarketview
prismmarketview Oct. 17 at 2:48 PM
$IRON Disc Medicine gained attention after receiving an FDA Commissioner’s National Priority Voucher for its rare-disease therapy bitopertin, aimed at treating erythropoietic protoporphyria (EPP). The voucher could cut the FDA review time to as little as 1–2 months, accelerating potential approval of a therapy designed to address the root cause of this painful, light-sensitive disorder. https://prismmarketview.com/disc-medicine-receives-fda-priority-voucher-for-bitopertin-in-rare-blood-disorder/
0 · Reply
topstockalerts
topstockalerts Oct. 17 at 2:38 PM
$IRON sector heating up.. stay tuned!
0 · Reply
MaverikIT
MaverikIT Oct. 17 at 2:24 PM
@IsabellaDC @TheLongVol taking your $IRON this AM ? $RVMD
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 2:20 PM
Cantor Fitzgerald updates rating for Disc Medicine ( $IRON ) to Overweight, target set at 132 → 153.
0 · Reply
techNICKaltrader
techNICKaltrader Oct. 17 at 2:08 PM
$IRON boom 95 tgt hit!!!
0 · Reply
techNICKaltrader
techNICKaltrader Oct. 17 at 2:03 PM
$IRON close over 90 and we go 95.
0 · Reply
topstockalerts
topstockalerts Oct. 17 at 1:58 PM
$IRON can’t say you weren’t warned.. 🔥 who wants the next one? Leave a like
0 · Reply
S_Franconi
S_Franconi Oct. 17 at 1:56 PM
$IRON Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week
0 · Reply